Humana (NYSE:HUM) Trading 1.4% Higher

Humana Inc. (NYSE:HUM) shares rose 1.4% during mid-day trading on Monday . The company traded as high as $334.42 and last traded at $332.88. Approximately 268,844 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 1,974,940 shares. The stock had previously closed at $328.33.

Analyst Ratings Changes

HUM has been the subject of a number of analyst reports. TheStreet lowered shares of Humana from a “b” rating to a “c+” rating in a report on Monday, January 8th. The Goldman Sachs Group dropped their price objective on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Truist Financial reissued a “hold” rating and issued a $550.00 price objective on shares of Humana in a report on Friday, January 19th. Argus cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Finally, Jefferies Financial Group reduced their price target on shares of Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday. Eleven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $454.63.

Humana Stock Up 0.8 %

The firm has a market cap of $39.55 billion, a price-to-earnings ratio of 16.54, a P/E/G ratio of 1.91 and a beta of 0.45. The firm has a 50 day moving average price of $329.86 and a 200-day moving average price of $398.38. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63.

Humana (NYSE:HUM) last posted its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The company had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. The company’s revenue for the quarter was up 17.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.62 EPS. On average, equities analysts forecast that Humana Inc. will post 16.06 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.08%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 17.86%.

Insider Activity

In other news, Director Jorge S. Mesquita acquired 545 shares of Humana stock in a transaction dated Tuesday, February 20th. The shares were acquired at an average cost of $367.09 per share, with a total value of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.29% of the company’s stock.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently bought and sold shares of HUM. Exchange Traded Concepts LLC lifted its position in Humana by 103.0% during the 3rd quarter. Exchange Traded Concepts LLC now owns 2,883 shares of the insurance provider’s stock worth $1,403,000 after acquiring an additional 1,463 shares in the last quarter. Caprock Group LLC raised its position in shares of Humana by 3.6% in the 3rd quarter. Caprock Group LLC now owns 1,421 shares of the insurance provider’s stock valued at $693,000 after purchasing an additional 50 shares in the last quarter. UMB Bank n.a. raised its position in shares of Humana by 2.8% in the 3rd quarter. UMB Bank n.a. now owns 805 shares of the insurance provider’s stock valued at $392,000 after purchasing an additional 22 shares in the last quarter. Czech National Bank raised its position in shares of Humana by 46.4% in the 3rd quarter. Czech National Bank now owns 21,656 shares of the insurance provider’s stock valued at $10,536,000 after purchasing an additional 6,866 shares in the last quarter. Finally, Aaron Wealth Advisors LLC acquired a new position in shares of Humana in the 3rd quarter valued at approximately $213,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.